AIG
PEAR

American International Group’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

American International Group’s Portfolio PEAR Stock Details PEAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-33,579
Closed -$8.56K – 3267
2023
Q1 		$8.56K Buy
33,579
+1,163
+4% +$1.05K ﹤0.01% 2956
2022
Q4 		$38.3K Sell
32,416
-118
-0.4% -$248 ﹤0.01% 2822
2022
Q3 		$66K Buy
+32,534
New +$55.2K ﹤0.01% 2733

American International Group's PEAR Position: Q2 2023 in Review

American International Group sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q2 2023, closing a stake of 33,579 shares — an estimated $8.56K sold.

American International Group first reported a position in PEAR in Q3 2022 and held it in 3 quarters. The position peaked at $66K in Q3 2022. 1 fund tracked by Wall St. Rank holds PEAR as of Q2 2023.

  • American International Group reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • American International Group sold 33,579 Pear Therapeutics, Inc. Class A Common Stock shares in Q2 2023, an estimated $8.56K.
  • American International Group first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q3 2022 and held it in 3 quarters.
  • American International Group's Pear Therapeutics, Inc. Class A Common Stock position peaked at $66K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q2 2023.

Based on American International Group's 13F filing for Q2 2023, filed 4 Aug 2023.